ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,139.83
0.75%
Dow Jones
38,239.66
0.40%
Gold vs US Dollar
2,337.935
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,875.01
0.73%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Concert Pharmaceuticals Inc (CNCE)

  7. Concert Pharmaceuticals Inc (CNCE) News

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNCE
DateTimeSourceHeadlineSymbolCompany
16/03/202313:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202310:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:58Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202316:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202314:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202314:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
06/03/202314:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
24/02/202321:06Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
24/02/202321:03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
16/02/202313:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
16/02/202313:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
16/02/202313:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202312:00Business WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202322:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202319:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
13/02/202314:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE

Your Recent History

LSE
MTRO
Metro Bank
LSE
SBTX
Skinbiotherapeutics
LSE
AAU
Ariana Resources
LSE
SCE
Surface Transforms
LSE
BARC
Barclays
LSE
BOO
Boohoo
LSE
ENET
Ethernity Networks
LSE
LGEN
Legal & General
LSE
TYM
Tertiary Minerals
LSE
MNL
Manchester & London Inve...
LSE
ZED
Zenova
LSE
HE1
Helium One Global
LSE
FTC
Filtronic
LSE
GCM
Gcm Resources
LSE
GKP
Gulf Keystone Petroleum
LSE
CNE
Capricorn Energy
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved